X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in ...

TRIMTECH Therapeutics raises $31M to enhance its TRIMTAC platform, targeting protein aggregates in neurodegenerative diseases for improved therapeutic outcomes.

According to the latest information released by the Fungicide Resistance Action Committee (FRAC), over 30 fungicide selective targets have been identified and acknowledged in the field of fungicide ...

Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of CNS penetrant therapeutics.

Cambridge biotech TRIMTECH Therapeutics, which is harnessing targeted protein degradation for the treatment of neurodegenerative diseases, has closed an oversubscribed $31 million (£25m) seed round ...

However, by comparing datasets of mammoth and elephant genomes, the team identified that mammoths lost the function of one of these genes. The researchers also introduced mutations into two of the ...

Researchers at Yale have achieved a major breakthrough in synthetic biology. They have rewritten the genetic code of an ...

For DeepTech funder Cambridge Innovation Capital, it’s a case of back to the future after its decision to take venture ...

Mary Berry’s simple recipe calls for just three ingredients ― egg, milk, and flour, along with a little oil.

Alltrna’s CEO Michelle Warner said that the approach allows for basket trials that can group patients with different diseases ...

Police said that a joint team of Police and CRPF after receiving specific information launched codon and search operations in the Jamslan area of Mahore. During the search, the search party recovered ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...